Intensive Versus Conventional Digoxin Use in Patients With Heart Failure

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT02797145

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Hospital Ana Nery (from the registry)
Registry
  • NCT NCT02797145
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02797145. Randomized; no masking; primary purpose treatment. Start 2016-05 (registry gives no type); primary completion 2018-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intensive Versus Conventional Digoxin Use in Patients With Heart Failure
Acronym
ICHF
Condition
Heart Failure
Intervention (Drug)
Digoxin dose-adjusted
Intervention (Drug)
Standard dose
Lead sponsor
Hospital Ana Nery (class: other)

Record details

Record id
cardio:ct-nct02797145
Content hash
b8e9c42bfe3e845fc5a8018fbac357703fdcf6a12a6a241767e2ed4eba1f1335